Switch theme
Sign up to access all valuation multiples
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
1982
19K+
LTM Revenue $2.4B
LTM EBITDA $252M
$3.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Amedisys has a last 12-month revenue (LTM) of $2.4B and a last 12-month EBITDA of $252M.
In the most recent fiscal year, Amedisys achieved revenue of $2.3B and an EBITDA of $177M.
Amedisys expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Amedisys valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | XXX | $2.3B | XXX | XXX | XXX |
| Gross Profit | $1.0B | XXX | $1.0B | XXX | XXX | XXX |
| Gross Margin | 43% | XXX | 43% | XXX | XXX | XXX |
| EBITDA | $252M | XXX | $177M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 8% | XXX | XXX | XXX |
| EBIT | $224M | XXX | $210M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $150M | XXX | $43.2M | XXX | XXX | XXX |
| Net Margin | 6% | XXX | 2% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $74.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Amedisys's stock price is $94.
Amedisys has current market cap of $3.1B, and EV of $3.3B.
See Amedisys trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.3B | $3.1B | XXX | XXX | XXX | XXX | $4.51 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Amedisys has market cap of $3.1B and EV of $3.3B.
Amedisys's trades at 1.4x EV/Revenue multiple, and 18.3x EV/EBITDA.
Equity research analysts estimate Amedisys's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Amedisys has a P/E ratio of 20.6x.
See valuation multiples for Amedisys and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3.1B | XXX | $3.1B | XXX | XXX | XXX |
| EV (current) | $3.3B | XXX | $3.3B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 12.9x | XXX | 18.3x | XXX | XXX | XXX |
| EV/EBIT | 14.6x | XXX | 15.5x | XXX | XXX | XXX |
| EV/Gross Profit | 3.2x | XXX | n/a | XXX | XXX | XXX |
| P/E | 20.6x | XXX | 71.4x | XXX | XXX | XXX |
| EV/FCF | 16.2x | XXX | 15.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAmedisys's last 12 month revenue growth is 5%
Amedisys's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $43K for the same period.
Amedisys's rule of 40 is 10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Amedisys's rule of X is 22% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Amedisys and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 42% | XXX | XXX | XXX |
| Rule of 40 | 10% | XXX | 12% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $43K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 34% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Aveanna Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amedisys acquired XXX companies to date.
Last acquisition by Amedisys was XXXXXXXX, XXXXX XXXXX XXXXXX . Amedisys acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Amedisys founded? | Amedisys was founded in 1982. |
| Where is Amedisys headquartered? | Amedisys is headquartered in United States of America. |
| How many employees does Amedisys have? | As of today, Amedisys has 19K+ employees. |
| Who is the CEO of Amedisys? | Amedisys's CEO is Mr. Richard M. Ashworth. |
| Is Amedisys publicy listed? | Yes, Amedisys is a public company listed on NAS. |
| What is the stock symbol of Amedisys? | Amedisys trades under AMED ticker. |
| When did Amedisys go public? | Amedisys went public in 1994. |
| Who are competitors of Amedisys? | Similar companies to Amedisys include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Amedisys? | Amedisys's current market cap is $3.1B |
| What is the current revenue of Amedisys? | Amedisys's last 12 months revenue is $2.4B. |
| What is the current revenue growth of Amedisys? | Amedisys revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Amedisys? | Current revenue multiple of Amedisys is 1.4x. |
| Is Amedisys profitable? | Yes, Amedisys is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Amedisys? | Amedisys's last 12 months EBITDA is $252M. |
| What is Amedisys's EBITDA margin? | Amedisys's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Amedisys? | Current EBITDA multiple of Amedisys is 12.9x. |
| What is the current FCF of Amedisys? | Amedisys's last 12 months FCF is $201M. |
| What is Amedisys's FCF margin? | Amedisys's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Amedisys? | Current FCF multiple of Amedisys is 16.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
